Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroprevalence and Impact of Screening for Strongyloides Stercoralis in Bone Marrow Transplant Recipients in the UK

NCT04709848 is registered in ClinicalTrials.gov with Imperial College Healthcare NHS Trust as lead sponsor.

NCT NCT04709848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04709848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroprevalence and Impact of Screening for Strongyloides Stercoralis in Bone Marrow Transplant Recipients in the UK
Lead sponsor
Imperial College Healthcare NHS Trust
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2021
Completion date
December 31, 2021
Enrollment
480 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow transplant infection, strongyloidiasis